These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3570109)

  • 1. Decrease in blood coagulation factors II (prothrombin), VII, IX and X in the rat after a single oral dose of butylated hydroxytoluene.
    Takahashi O
    Food Chem Toxicol; 1987 Mar; 25(3):219-24. PubMed ID: 3570109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feeding of butylated hydroxytoluene to rats caused a rapid decrease in blood coagulation factors II (prothrombin), VII, IX and X.
    Takahashi O
    Arch Toxicol; 1986 Feb; 58(3):177-81. PubMed ID: 3964081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT quinone methide): an active metabolite of BHT causing haemorrhages in rats.
    Takahashi O
    Arch Toxicol; 1988; 62(4):325-7. PubMed ID: 3240097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT quinone methide) in the metabolism of butylated hydroxytoluene.
    Takahashi O; Hiraga K
    Food Chem Toxicol; 1983 Jun; 21(3):279-83. PubMed ID: 6683224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemorrhagic toxicosis in rats given butylated hydroxytoluene.
    Takahashi O; Hiraga K
    Acta Pharmacol Toxicol (Copenh); 1981 Jul; 49(1):14-20. PubMed ID: 7336960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatotropin and somatostatin effects on vitamin K-dependent plasma coagulation factors.
    Negrev N; Nyagolov Y; Stanchewa E
    Eur J Pharmacol; 1995 Apr; 277(2-3):145-9. PubMed ID: 7493602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity of butylated hydroxytoluene and its analogs in mice depleted of hepatic glutathione.
    Mizutani T; Nomura H; Nakanishi K; Fujita S
    Toxicol Appl Pharmacol; 1987 Jan; 87(1):166-76. PubMed ID: 3798451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric retention and delayed absorption of a large dose of butylated hydroxytoluene in the rat.
    Takahashi O
    Xenobiotica; 1990 Dec; 20(12):1319-29. PubMed ID: 2075750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K deficiency in male rats fed diets containing butylated hydroxytoluene (BHT).
    Suzuki H; Nakao T; Hiraga K
    Toxicol Appl Pharmacol; 1979 Sep; 50(2):261-6. PubMed ID: 92074
    [No Abstract]   [Full Text] [Related]  

  • 10. The dose-dependent effect of BHT (butylated hydroxytoluene) on vitamin K-dependent blood coagulation in rats.
    Cottrell S; Andrews CM; Clayton D; Powell CJ
    Food Chem Toxicol; 1994 Jul; 32(7):589-94. PubMed ID: 8045471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of warfarin on plasma concentrations of vitamin K dependent coagulation factors in patients with stable control and monitored compliance.
    Kumar S; Haigh JR; Tate G; Boothby M; Joanes DN; Davies JA; Roberts BE; Feely MP
    Br J Haematol; 1990 Jan; 74(1):82-5. PubMed ID: 2310700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of butylated hydroxytoluene-induced hepatic toxicity in rats.
    Nakagawa Y; Tayama K; Nakao T; Hiraga K
    Biochem Pharmacol; 1984 Aug; 33(16):2669-74. PubMed ID: 6466378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effects of phylloquinone on hemorrhagic death induced by butylated hydroxytoluene in male rats.
    Takahashi O; Hiraga K
    J Nutr; 1979 Mar; 109(3):453-7. PubMed ID: 430246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
    Thompson JA; Malkinson AM; Wand MD; Mastovich SL; Mead EW; Schullek KM; Laudenschlager WG
    Drug Metab Dispos; 1987; 15(6):833-40. PubMed ID: 2893710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the metabolism of butylated hydroxytoluene (BHT) and lung tumor promotion in mice.
    Thompson JA; Bolton JL; Malkinson AM
    Exp Lung Res; 1991; 17(2):439-53. PubMed ID: 2050043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced lung toxicity of butylated hydroxytoluene in mice by coadministration of butylated hydroxyanisole.
    Yamamoto K; Tajima K; Okino N; Mizutani T
    Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):219-31. PubMed ID: 3358012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of single oral doses of butylated hydroxytoluene in man and rat.
    Verhagen H; Beckers HH; Comuth PA; Maas LM; ten Hoor F; Henderson PT; Kleinjans JC
    Food Chem Toxicol; 1989 Dec; 27(12):765-72. PubMed ID: 2606406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and reactivity of alternative quinone methides from butylated hydroxytoluene: possible explanation for species-specific pneumotoxicity.
    Bolton JL; Sevestre H; Ibe BO; Thompson JA
    Chem Res Toxicol; 1990; 3(1):65-70. PubMed ID: 2131827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotope effects on the metabolism and pulmonary toxicity of butylated hydroxytoluene in mice by deuteration of the 4-methyl group.
    Mizutani T; Yamamoto K; Tajima K
    Toxicol Appl Pharmacol; 1983 Jun; 69(2):283-90. PubMed ID: 6868090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K2 (Menaquinone-7) supplementation does not affect vitamin K-dependent coagulation factors activity in healthy individuals.
    Ren R; Liu J; Cheng G; Tan J
    Medicine (Baltimore); 2021 Jun; 100(23):e26221. PubMed ID: 34115006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.